Skandinaviska Enskilda Banken (SEB)’s Vigil Neuroscience VIGL Stock Holding History

Skandinaviska Enskilda Banken (SEB)’s Portfolio VIGL Stock Details VIGL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-275,998	Closed	-$2.19M	–	891
2025 Q2	$2.19M	Buy	+275,998	New	+$1.24M	0.01%	568

Other funds holding VIGL

Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return

Skandinaviska Enskilda Banken (SEB)'s VIGL Position: Q3 2025 in Review

Skandinaviska Enskilda Banken (SEB) sold out of Vigil Neuroscience (VIGL) in Q3 2025, closing a stake of 275,998 shares — an estimated $2.19M sold.

Skandinaviska Enskilda Banken (SEB) first reported a position in VIGL in Q2 2025 and held it in 1 quarter. The position peaked at $2.19M in Q2 2025. 2 funds tracked by Wall St. Rank hold VIGL as of Q3 2025.

Skandinaviska Enskilda Banken (SEB) reported no remaining Vigil Neuroscience position as of Q3 2025 after selling out during the quarter.
Skandinaviska Enskilda Banken (SEB) sold 275,998 Vigil Neuroscience shares in Q3 2025, an estimated $2.19M.
Skandinaviska Enskilda Banken (SEB) first reported a position in Vigil Neuroscience in Q2 2025 and held it in 1 quarter.
Skandinaviska Enskilda Banken (SEB)'s Vigil Neuroscience position peaked at $2.19M in Q2 2025.
2 funds tracked by Wall St. Rank held Vigil Neuroscience as of Q3 2025.

Based on Skandinaviska Enskilda Banken (SEB)'s 13F filing for Q3 2025, filed 7 Nov 2025.